Amanote Research
Register
Sign In
Tumor-Selective Delivery of Antisense Oligomers (antimiRs) Against Oncogenic microRNAs
Science-Business eXchange
doi 10.1038/scibx.2014.1418
Full Text
Open PDF
Abstract
Available in
full text
Date
December 1, 2014
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Tumor-Stromal Cross Talk: Direct Cell-To-Cell Transfer of Oncogenic microRNAs via Tunneling Nanotubes
Translational Research
Biochemistry
Public Health
Environmental
Medicine
Physiology
Occupational Health
Transcatheter Delivery of C-Myc Antisense Oligomers Reduces Neointimal Formation in a Porcine Model of Coronary Artery Balloon Injury
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Long-Circulating Polymeric Nanovectors for Tumor-Selective Gene Delivery
Technology in Cancer Research and Treatment
Medicine
Cancer Research
Oncology
Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth
PLoS ONE
Multidisciplinary
Circulating microRNAs in Oncogenic Viral Infections: Potential Diagnostic Biomarkers
SN Applied Sciences
Tumor-Penetrating Delivery of siRNA Against TNFα to Human Vestibular Schwannomas
Scientific Reports
Multidisciplinary
Targeted Delivery of Antisense Oligonucleotides to Pancreatic Β-Cells
Science advances
Multidisciplinary
Targeted Nanoparticle Delivery of Therapeutic Antisense microRNAs Presensitizes Glioblastoma Cells to Lower Effective Doses of Temozolomide in Vitro and in a Mouse Model
Oncotarget
Oncology
An Assessment of the Antisense Properties of RNase H-Competent and Steric-Blocking Oligomers
Nucleic Acids Research
Genetics
